Blume-Jensen Peter

CIK 1950499
Transactions on file
18

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-05-262026-05-21ACRV
Acrivon Therapeutics, Inc.
President and CEO
Tax13,729$24.6K-19.6%open →
2026-05-202026-05-18ACRV
Acrivon Therapeutics, Inc.
President and CEO
Grant72,706$0.00open →
2026-05-202026-05-18ACRV
Acrivon Therapeutics, Inc.
President and CEO
Grant180,095$0.00open →
2026-05-182026-05-14ACRV
Acrivon Therapeutics, Inc.
President and CEO
Tax490$940.80-25.0%open →
2026-05-182026-05-14ACRV
Acrivon Therapeutics, Inc.
President and CEO
Tax1,253$2.4K-25.0%open →
2025-02-192025-02-14ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax579$3.1K-73.4%open →
2025-02-192025-02-14ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax37,152$201.4K-73.4%open →
2025-02-252025-02-21ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax19,904$110.3K-74.0%open →
2025-05-162025-05-14ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax59,766$68.1K+26.3%open →
2025-05-162025-05-14ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax491$559.74+26.3%open →
2025-05-232025-05-21ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax19,904$22.9K+25.2%open →
2026-02-242026-02-21ACRV
Acrivon Therapeutics, Inc.
President and CEO
Tax14,265$21.8K-5.9%open →
2025-11-252025-11-21ACRV
Acrivon Therapeutics, Inc.
President and CEO
Tax19,904$45.8K-37.4%open →
2025-11-182025-11-14ACRV
Acrivon Therapeutics, Inc.
President and CEO
Tax490$1.1K-35.7%open →
2025-11-182025-11-14ACRV
Acrivon Therapeutics, Inc.
President and CEO
Tax59,765$133.9K-35.7%open →
2025-08-182025-08-14ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax59,766$83.1K+3.6%open →
2025-08-182025-08-14ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax490$681.10+3.6%open →
2025-08-252025-08-21ACRV
Acrivon Therapeutics, Inc.
OfficerDirector
President and CEO
Tax19,905$26.3K+9.1%open →